Maple Leaf Foods plans to bring its U.S. plant-protein manufacturing together at its Indianapolis facility, according to a September 22, 2026 Canadian Press report carried by CTV News.
The company says production at Seattle and Turners Falls, Massachusetts, will wind down as part of the consolidation. Both sites are expected to keep operating during the transition. Maple Leaf estimates that process will take 12 to 18 months, with completion expected in the fourth quarter of 2027.
Maple Leaf presents the move as part of its strategy to simplify its manufacturing network and improve competitiveness and profitability. Those are company objectives; the announcement does not establish that the savings or improvements have already occurred.
The report does not specify how many jobs will be affected. It concerns U.S. plant-protein operations and does not announce a Canadian plant closure.
